PPARĪ³ is an interesting target for cancer therapy not only because of its elevated expression in tumors, but also because PPARĪ³ activation results in decreased cell proliferation, decreased G/G to S phase progression, increased terminal differentiation, and apoptosis [11], [12], [13].
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}